Do all young ischemic stroke patients need long-term secondary preventive medication?
After a mean of 6 years, the frequencies of later vascular events (recurrent ischemic stroke or myocardial infarction) in 232 young ischemic stroke patients (younger than 50 years) with none to five traditional risk factors were 2.1%, 6%, 19%, 26%, 30%, and 67% (p < 0.001). Long-term secondary preventive medication may not be indicated in young ischemic stroke patients with no risk factor.
Naess
H
H
Department of Neurology, Haukeland University Hospital, University of Bergen, N-5021 Bergen, Norway. halvor.naess@haukeland.no
Waje-Andreassen
U
U
Thomassen
L
L
Nyland
H
H
Myhr
K M
KM
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000150:complications / Q000453:epidemiology / Q000517:prevention & control; D009664:Norway / Q000453:epidemiology; D012189:Retrospective Studies; D012307:Risk Factors; D055502:Secondary Prevention; D020521:Stroke / Q000188:drug therapy* / Q000453:epidemiology / Q000517:prevention & control*; D014057:Tomography, X-Ray Computed
D000925:Anticoagulants